Vertex Pharmaceuticals Inc. (VRTX): Price and Financial Metrics


Vertex Pharmaceuticals Inc. (VRTX): $321.02

5.74 (+1.82%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add VRTX to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

VRTX POWR Grades

  • Quality is the dimension where VRTX ranks best; there it ranks ahead of 97.49% of US stocks.
  • The strongest trend for VRTX is in Quality, which has been heading down over the past 177 days.
  • VRTX's current lowest rank is in the Momentum metric (where it is better than 39.79% of US stocks).

VRTX Stock Summary

  • VRTX has a higher market value than 97.45% of US stocks; more precisely, its current market capitalization is $82,403,089,921.
  • Of note is the ratio of VERTEX PHARMACEUTICALS INC's sales and general administrative expense to its total operating expenses; merely 11.57% of US stocks have a lower such ratio.
  • With a price/sales ratio of 9.47, VERTEX PHARMACEUTICALS INC has a higher such ratio than 87.62% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to VERTEX PHARMACEUTICALS INC are MU, LRCX, REGN, AMAT, and INTC.
  • VRTX's SEC filings can be seen here. And to visit VERTEX PHARMACEUTICALS INC's official web site, go to www.vrtx.com.

VRTX Valuation Summary

  • VRTX's EV/EBIT ratio is 17.4; this is 75.76% higher than that of the median Healthcare stock.
  • VRTX's price/sales ratio has moved up 2.6 over the prior 243 months.

Below are key valuation metrics over time for VRTX.

Stock Date P/S P/B P/E EV/EBIT
VRTX 2023-01-20 9.1 6.1 24.3 17.4
VRTX 2023-01-19 9.1 6.1 24.1 17.3
VRTX 2023-01-18 9.1 6.1 24.3 17.4
VRTX 2023-01-17 9.2 6.1 24.5 17.6
VRTX 2023-01-13 8.9 5.9 23.6 16.9
VRTX 2023-01-12 8.7 5.8 23.2 16.6

VRTX Growth Metrics

    Its 3 year cash and equivalents growth rate is now at 162.63%.
  • Its year over year net cashflow from operations growth rate is now at -20.25%.
  • Its 2 year net cashflow from operations growth rate is now at 30.02%.
VRTX's revenue has moved up $4,537,740,000 over the prior 33 months.

The table below shows VRTX's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 8,700.561 4,046.493 3,273.21
2022-06-30 8,350.425 4,018.212 3,194.638
2022-03-31 7,947.595 2,678.645 2,451.062
2021-12-31 7,574.4 2,643.5 2,342.1
2021-09-30 7,129.659 2,140.039 2,176.18
2021-06-30 6,683.766 2,120.568 1,991.686

VRTX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • VRTX has a Quality Grade of B, ranking ahead of 86.88% of graded US stocks.
  • VRTX's asset turnover comes in at 0.564 -- ranking 66th of 681 Pharmaceutical Products stocks.
  • ORGO, MDWD, and CCXI are the stocks whose asset turnover ratios are most correlated with VRTX.

The table below shows VRTX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.564 0.879 0.725
2021-03-31 0.565 0.881 1.066
2020-12-31 0.589 0.881 1.053
2020-09-30 0.619 0.880 1.013
2020-06-30 0.618 0.877 0.796
2020-03-31 0.607 0.872 0.605

VRTX Price Target

For more insight on analysts targets of VRTX, see our VRTX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $258.59 Average Broker Recommendation 1.54 (Moderate Buy)

VRTX Stock Price Chart Interactive Chart >

Price chart for VRTX

VRTX Price/Volume Stats

Current price $321.02 52-week high $324.75
Prev. close $315.28 52-week low $225.28
Day low $314.60 Volume 1,301,900
Day high $321.11 Avg. volume 1,429,406
50-day MA $304.98 Dividend yield N/A
200-day MA $288.45 Market Cap 82.40B

Vertex Pharmaceuticals Inc. (VRTX) Company Bio


Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in South Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, near Oxford, England. (Source:Wikipedia)


VRTX Latest News Stream


Event/Time News Detail
Loading, please wait...

VRTX Latest Social Stream


Loading social stream, please wait...

View Full VRTX Social Stream

Latest VRTX News From Around the Web

Below are the latest news stories about VERTEX PHARMACEUTICALS INC that investors may wish to consider to help them evaluate VRTX as an investment opportunity.

Dow Jones Falls 325 Points As Boeing, Microsoft Drop On Earnings; Tesla Skids Ahead Of Earnings

The Dow Jones dropped 300 points Wednesday, as Boeing and Microsoft fell on earnings. Tesla earnings are due after the close.

Yahoo | January 25, 2023

Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know

In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $313.57, marking a +0.56% move from the previous day.

Yahoo | January 24, 2023

Dow Jones Falls 200 Points With 8 Key Earnings Movers; Microsoft Earnings Due

The Dow Jones Industrial Average fell 180 points Tuesday as J&J and Verizon reported earnings. Microsoft earnings are due out after the stock market close.

Yahoo | January 24, 2023

Healthcare Sector Is Lagging As We Enter 2022 Earnings Season

The healthcare sector is perceived as defensive but in 2023 there is more investor appetite for risk based on the QQQ comeback and the XBI strength.

TalkMarkets.com | January 23, 2023

Stocks To Buy And Watch: Dow Jones Banking Giant JPMorgan, 3 Others In Or Near Buy Zones

Among the top stocks to buy and watch, Dow Jones banking giant JPMorgan is below its recent buy point, while Axon is breaking out today.

Yahoo | January 23, 2023

Read More 'VRTX' Stories Here

VRTX Price Returns

1-mo 12.34%
3-mo 2.27%
6-mo 14.48%
1-year 40.66%
3-year 38.39%
5-year 89.72%
YTD 11.16%
2022 31.50%
2021 -7.08%
2020 7.94%
2019 32.13%
2018 10.58%

Continue Researching VRTX

Want to see what other sources are saying about Vertex Pharmaceuticals Inc's financials and stock price? Try the links below:

Vertex Pharmaceuticals Inc (VRTX) Stock Price | Nasdaq
Vertex Pharmaceuticals Inc (VRTX) Stock Quote, History and News - Yahoo Finance
Vertex Pharmaceuticals Inc (VRTX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9469 seconds.